ArticleInternational journal of nanomedicine2025
Green Synthesis: An Eco-Friendly Approach for the Synthesis of Silver Nanoparticles Functionalized with
Article in International journal of nanomedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Green-synthesizedRSC advances · 2026Article
- Antimicrobial effects of nanosilver/polyethylene glycol/chitosan in cesarean section and their impact on breastfeeding rates.BMC surgery · 2025Article
- The Antimicrobial Activity of Silver Nanoparticles Biosynthesized UsingPharmaceuticals (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Silver nanoparticles (AgNPs) have gained significant attention in biomedical applications. Green synthesis methods provide an eco-friendly and cost-effective approach to AgNPs production, utilizing plant extracts as reducing and stabilizing agents. In this study, AgNPs were synthesized using the methanolic extract of Methodology: AgNPs were synthesized using Results: AgNPs exhibited an inhibition zone of 14 mm against Discussion: The enhanced antibacterial activity of AgNPs suggests improved bioavailability and interaction with bacterial membranes. The strong enzyme inhibitory potential indicates their possible therapeutic role in enzyme-related disorders. The analgesic and sedative activity of AgNPs suggests their possible role in pain management agents and neuropharmacology. The results demonstrate the efficacy of green-synthesized AgNPs for biomedical applications. Conclusion: Green synthesized AgNPs and their antibacterial, enzyme inhibitory, analgesic, and sedative properties suggest promising therapeutic applications. Further research should explore their mechanisms and in vivo safety for clinical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.